Literature DB >> 25900325

Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.

Uri R Mbonye1, Benlian Wang2, Giridharan Gokulrangan2, Mark R Chance2, Jonathan Karn1.   

Abstract

Efficient HIV transcription requires P-TEFb, an essential co-factor for Tat. In actively replicating cells, P-TEFb is incorporated into the 7SK snRNP complex together with the repressor protein HEXIM1. Using an affinity purification-tandem mass spectrometry approach to identify modification sites on HEXIM1 that regulate the sequestration of P-TEFb by 7SK snRNP, we found that HEXIM1 can be phosphorylated on adjacent residues in a region immediately upstream of the coiled-coil dimerization domain (Ser268, Thr270, Tyr271, and Tyr274). Phosphomimetic mutations of Tyr271 and Tyr274 disrupted the assembly of P-TEFb and HEXIM1 into the 7SK snRNP complex. Although Y271E/Y274E did not adversely affect the nuclear localization pattern of HEXIM1, it induced the redistribution of the CDK9 subunit of P-TEFb into the cytoplasm. By contrast, the Y271F/Y274F HEXIM1 mutant assembled normally with P-TEFb within the 7SK snRNP complex but severely reduced proviral gene expression in T cells in response to activation signals and caused a severe growth defect of Jurkat T cells. Thus, Y271F/Y274F, which cannot be phosphorylated on these residues, appears to block the exchange of active P-TEFb from the 7SK complex, thereby limiting the level of P-TEFb below the threshold required to support transcription elongation of the HIV provirus and cellular genes.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  7SK RNP complex; HEXIM1 phosphorylation; HIV Tat; Microbiology; P-TEFb

Mesh:

Substances:

Year:  2015        PMID: 25900325      PMCID: PMC4487608          DOI: 10.1002/pmic.201500038

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  26 in total

1.  Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.

Authors:  Qintong Li; Jason P Price; Sarah A Byers; Dongmei Cheng; Junmin Peng; David H Price
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

2.  Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb.

Authors:  Sonja A Dames; André Schönichen; Antje Schulte; Matjaz Barboric; B Matija Peterlin; Stephan Grzesiek; Matthias Geyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

3.  Phosphorylation of RNAPII: To P-TEFb or not to P-TEFb?

Authors:  Bartlomiej Bartkowiak; Arno L Greenleaf
Journal:  Transcription       Date:  2011-05

4.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

5.  T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.

Authors:  Young Kyeung Kim; Uri Mbonye; Joseph Hokello; Jonathan Karn
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

6.  T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.

Authors:  Eugene C Dow; Hongbing Liu; Andrew P Rice
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

7.  7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription.

Authors:  B Matija Peterlin; John E Brogie; David H Price
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-18       Impact factor: 9.957

8.  The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.

Authors:  Bryan M Wittmann; Koh Fujinaga; Huayun Deng; Ndiya Ogba; Monica M Montano
Journal:  Oncogene       Date:  2005-08-25       Impact factor: 9.867

9.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

10.  Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.

Authors:  Sungyoo Cho; Sebastian Schroeder; Katrin Kaehlcke; Hye-Sook Kwon; Angelika Pedal; Eva Herker; Martina Schnoelzer; Melanie Ott
Journal:  EMBO J       Date:  2009-04-23       Impact factor: 11.598

View more
  12 in total

1.  An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb.

Authors:  Lydia Kobbi; Emmanuelle Demey-Thomas; Floriane Braye; Florence Proux; Olga Kolesnikova; Joelle Vinh; Arnaud Poterszman; Olivier Bensaude
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-25       Impact factor: 11.205

2.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

Review 3.  Hexim1, an RNA-controlled protein hub.

Authors:  Annemieke A Michels; Olivier Bensaude
Journal:  Transcription       Date:  2018-02-23

Review 4.  Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.

Authors:  Guillaume Mousseau; Susana T Valente
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

5.  Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Authors:  Uri Mbonye; Benlian Wang; Giridharan Gokulrangan; Wuxian Shi; Sichun Yang; Jonathan Karn
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

6.  Regulation of RNA polymerase II activity is essential for terminal erythroid maturation.

Authors:  Zachary C Murphy; Kristin Murphy; Jacquelyn Myers; Michael Getman; Tyler Couch; Vincent P Schulz; Kimberly Lezon-Geyda; Cal Palumbo; Hongxia Yan; Narla Mohandas; Patrick G Gallagher; Laurie A Steiner
Journal:  Blood       Date:  2021-11-04       Impact factor: 22.113

7.  HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells.

Authors:  Mark B Lucera; Zach Fleissner; Caroline O Tabler; Daniela M Schlatzer; Zach Troyer; John C Tilton
Journal:  Retrovirology       Date:  2017-01-24       Impact factor: 4.602

Review 8.  CDK9 keeps RNA polymerase II on track.

Authors:  Sylvain Egloff
Journal:  Cell Mol Life Sci       Date:  2021-06-19       Impact factor: 9.261

9.  An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.

Authors:  Gilles Darcis; Anna Kula; Sophie Bouchat; Koh Fujinaga; Francis Corazza; Amina Ait-Ammar; Nadège Delacourt; Adeline Melard; Kabamba Kabeya; Caroline Vanhulle; Benoit Van Driessche; Jean-Stéphane Gatot; Thomas Cherrier; Luiz F Pianowski; Lucio Gama; Christian Schwartz; Jorge Vila; Arsène Burny; Nathan Clumeck; Michel Moutschen; Stéphane De Wit; B Matija Peterlin; Christine Rouzioux; Olivier Rohr; Carine Van Lint
Journal:  PLoS Pathog       Date:  2015-07-30       Impact factor: 6.823

Review 10.  Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb.

Authors:  Alexandre J C Quaresma; Andrii Bugai; Matjaz Barboric
Journal:  Nucleic Acids Res       Date:  2016-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.